1,1-dichloroethene decreases expression ISO RGD:736146 6480464 vinylidene chloride results in decreased expression of FBLN5 mRNA CTD PMID:26682919 17alpha-ethynylestradiol affects expression ISO RGD:736146 6480464 Ethinyl Estradiol affects the expression of FBLN5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FBLN5 mRNA CTD PMID:15576828 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FBLN5 mRNA CTD PMID:17108234 17beta-estradiol multiple interactions ISO RGD:736145 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FBLN5 mRNA CTD PMID:30165855 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of FBLN5 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:736146 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FBLN5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:736146 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of FBLN5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:736146 6480464 bis4-hydroxyphenylsulfone results in increased expression of FBLN5 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FBLN5 mRNA CTD PMID:24780913 aflatoxin B1 increases methylation ISO RGD:736145 6480464 Aflatoxin B1 results in increased methylation of FBLN5 gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:736146 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of FBLN5 mRNA more ... CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FBLN5 mRNA CTD PMID:16483693 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of FBLN5 mRNA CTD PMID:23912714 arsenous acid increases expression ISO RGD:736145 6480464 Arsenic Trioxide results in increased expression of FBLN5 mRNA CTD PMID:15761015 benzo[a]pyrene decreases expression ISO RGD:736146 6480464 Benzoapyrene results in decreased expression of FBLN5 mRNA CTD PMID:20713471 benzo[a]pyrene increases expression ISO RGD:736146 6480464 Benzoapyrene results in increased expression of FBLN5 mRNA CTD PMID:22610609 benzo[e]pyrene increases methylation ISO RGD:736145 6480464 benzoepyrene results in increased methylation of FBLN5 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN5 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736145 6480464 Diethylhexyl Phthalate results in increased expression of FBLN5 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBLN5 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:736146 6480464 bisphenol A results in increased expression of FBLN5 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:736146 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of FBLN5 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:736145 6480464 bisphenol A results in increased expression of FBLN5 mRNA CTD PMID:29275510 bisphenol F multiple interactions ISO RGD:736146 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of FBLN5 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:736146 6480464 bisphenol F results in increased expression of FBLN5 mRNA CTD PMID:30951980 bortezomib decreases expression ISO RGD:736145 6480464 Bortezomib results in decreased expression of FBLN5 mRNA CTD PMID:20977926 butanal increases expression ISO RGD:736145 6480464 butyraldehyde results in increased expression of FBLN5 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:736145 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBLN5 mRNA CTD PMID:29741670 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FBLN5 mRNA CTD PMID:25993096 cadmium dichloride multiple interactions ISO RGD:736145 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBLN5 mRNA CTD PMID:29741670 cadmium dichloride increases expression ISO RGD:736145 6480464 Cadmium Chloride results in increased expression of FBLN5 mRNA CTD PMID:26314618 carbon nanotube decreases expression ISO RGD:736146 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of FBLN5 mRNA CTD PMID:16005536 choline multiple interactions ISO RGD:736146 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBLN5 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:736146 6480464 Ciguatoxins affects the expression of FBLN5 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:736145 6480464 Cisplatin results in increased expression of FBLN5 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FBLN5 mRNA CTD PMID:24386269 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 protein CTD PMID:22276220 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 protein CTD PMID:22276220 crocidolite asbestos increases expression ISO RGD:736145 6480464 Asbestos, Crocidolite results in increased expression of FBLN5 protein CTD PMID:29553831 dexamethasone decreases expression ISO RGD:736146 6480464 Dexamethasone results in decreased expression of FBLN5 mRNA CTD PMID:25056791 dextran sulfate multiple interactions ISO RGD:736146 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN5 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:736145 6480464 Arsenic Trioxide results in increased expression of FBLN5 mRNA CTD PMID:15761015 dioxygen increases expression ISO RGD:736145 6480464 Oxygen deficiency results in increased expression of FBLN5 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:736145 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of FBLN5 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:736145 6480464 Doxorubicin results in decreased expression of FBLN5 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:736145 6480464 Selenium results in increased expression of FBLN5 mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:736145 6480464 entinostat results in increased expression of FBLN5 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:736146 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FBLN5 mRNA CTD PMID:30517762 ethanol affects expression ISO RGD:736146 6480464 Ethanol affects the expression of FBLN5 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:736146 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBLN5 mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of FBLN5 mRNA CTD PMID:27387713 L-methionine multiple interactions ISO RGD:736146 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBLN5 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:736145 6480464 Lead affects the expression of FBLN5 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:736145 6480464 Lead affects the expression of FBLN5 mRNA CTD PMID:28903495 methapyrilene increases methylation ISO RGD:736145 6480464 Methapyrilene results in increased methylation of FBLN5 intron CTD PMID:30157460 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of FBLN5 mRNA CTD PMID:16005536 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN5 mRNA CTD PMID:18164116 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of FBLN5 mRNA CTD PMID:22110744 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FBLN5 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:736146 6480464 Acetaminophen affects the expression of FBLN5 mRNA CTD PMID:17562736 pentanal increases expression ISO RGD:736145 6480464 pentanal results in increased expression of FBLN5 mRNA CTD PMID:26079696 phenylmercury acetate increases expression ISO RGD:736145 6480464 Phenylmercuric Acetate results in increased expression of FBLN5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736145 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of FBLN5 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:736146 6480464 Phosgene affects the expression of FBLN5 mRNA CTD PMID:16300373 potassium dichromate increases expression ISO RGD:736146 6480464 Potassium Dichromate results in increased expression of FBLN5 mRNA CTD PMID:23608068 progesterone increases expression ISO RGD:736145 6480464 Progesterone results in increased expression of FBLN5 mRNA CTD PMID:21795739 propanal increases expression ISO RGD:736145 6480464 propionaldehyde results in increased expression of FBLN5 mRNA CTD PMID:26079696 resveratrol increases expression ISO RGD:736145 6480464 resveratrol results in increased expression of FBLN5 mRNA CTD PMID:25888808 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FBLN5 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:736145 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of FBLN5 mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:736145 6480464 Selenium results in increased expression of FBLN5 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:736145 6480464 Silicon Dioxide analog results in decreased expression of FBLN5 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:736146 6480464 Silver results in decreased expression of FBLN5 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:736146 6480464 Silver results in decreased expression of FBLN5 mRNA CTD PMID:27131904 sodium arsenite affects methylation ISO RGD:736145 6480464 sodium arsenite affects the methylation of FBLN5 gene CTD PMID:28589171 Soman increases expression EXP 6480464 Soman results in increased expression of FBLN5 mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:736145 6480464 Sunitinib results in decreased expression of FBLN5 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:736146 6480464 Tamoxifen affects the expression of FBLN5 mRNA CTD PMID:17555576 tetrachloromethane increases expression ISO RGD:736146 6480464 Carbon Tetrachloride results in increased expression of FBLN5 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:736146 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FBLN5 mRNA CTD PMID:30517762 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of FBLN5 protein CTD PMID:22276220 tioguanine decreases expression EXP 6480464 Thioguanine results in decreased expression of FBLN5 mRNA CTD PMID:16005536 titanium dioxide decreases expression ISO RGD:736146 6480464 titanium dioxide results in decreased expression of FBLN5 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions ISO RGD:736146 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN5 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FBLN5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of FBLN5 mRNA CTD PMID:25729387 triclosan increases expression ISO RGD:736145 6480464 Triclosan results in increased expression of FBLN5 mRNA CTD PMID:30510588 troglitazone decreases expression ISO RGD:736146 6480464 troglitazone results in decreased expression of FBLN5 mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:736146 6480464 troglitazone results in increased expression of FBLN5 mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:736146 6480464 Urethane results in decreased expression of FBLN5 mRNA CTD PMID:16289808 valproic acid increases expression ISO RGD:736145 6480464 Valproic Acid results in increased expression of FBLN5 mRNA CTD PMID:23179753 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FBLN5 mRNA CTD PMID:29427782 valproic acid increases methylation ISO RGD:736145 6480464 Valproic Acid results in increased methylation of FBLN5 gene CTD PMID:29154799 zoledronic acid increases expression ISO RGD:736145 6480464 zoledronic acid results in increased expression of FBLN5 mRNA CTD PMID:24714768